Sanjay Rajagopalan, MD
Cardiology, Radiology-Cardiothoracic Imaging
Accepting New Patients
Schedule an Appointment
- Chief, Division of Cardiovascular Medicine, UH Harrington Heart and Vascular Institute, University Hospitals
- Division Chief, Cardiovascular Medicine, UH Cleveland Medical Center
- Director, Center for Advanced Heart and Vascular Care, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Dr. Sanjay Rajagopalan is the Chief of Cardiovascular Medicine for University Hospitals Harrington Heart & Vascular Institute, the Herman K. Hellerstein, MD Professor of Cardiovascular Research, and Director of the Case Cardiovascular Research Institute at Case Western Reserve University School of Medicine in Cleveland, Ohio.
Dr. Rajagopalan completed internal medicine training, including serving as Chief Resident, at SUNY (Buffalo, New York), Clinical and Research Fellowships in Cardiovascular Medicine/Vascular Biology at the Emory University School of Medicine (Atlanta, Georgia) and Cardiovascular Magnetic Resonance Imaging training at Duke University Medical Center (Durham, North Carolina).
Dr. Rajagopalan is among an elite group of physician scientists whose work has helped transform global perceptions of the impact of the environment on cardiovascular health. He is passionate about technology innovation in cardiovascular medicine for the development of personalized approaches to heart disease prevention.
Dr. Rajagopalan is an elected member of the American Society of Clinical Investigation (ASCI), American Association of Physicians (AAP), Association of University Cardiologists (AUC) and the Association of Professors of Cardiology (APC).
- Advanced Cardiovascular Imaging
- Cardiovascular Medicine
- Cardiovascular Prevention
- Computed Tomography (CT)
- Lipid Management
- Magnetic Resonance Imaging (MRI)
- Preventive Cardiology
- Vascular Medicine
CMC Mather Ste 1800 HHVI
11100 Euclid Ave
Cleveland OH, 44106
UH Minoff Health Center at Chagrin Highlands
3909 Orange Pl
Beachwood OH, 44122
Certifications & Memberships
- Cardiovascular Disease - American Board of Internal Medicine
Fellowship | Cardiovascular Medicine
Cardiovascular Medicine - Duke University Medical Center (2003 - 2004)
Research Fellowship | Cardiovascular Medicine
Cardiovascular Medicine - Cornell University (2001 - 2002)
Fellowship | Cardiovascular Disease
Cardiovascular Disease - Emory University Hospital (1994 - 1998)
Residency | Internal Medicine
Internal Medicine - Erie County Medical Center (1990 - 1994)
University Of Madras, India (1990)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Sanjay Rajagopalan did not disclose any Outside Relationships with Industry.